The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era
Zheng Li, Yue Hu, M. Zeng, Qinyong Hu, Fei Ye, Ruifeng Liu, Hongyi Cai, Qiang Li, Xiaohu Wang
Abstract
The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Radiation therapyMedicineLiver cancerPandemicCancer2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)OncologyInternal medicinePathologyDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 and healthcare impactsEffects of Radiation ExposureHepatocellular Carcinoma Treatment and Prognosis